FDA Inspection
Rxhomeo Private LimitedRxhomeo Private Limited – FDA Inspection, May 19, 2023
Record Details
This FDA Inspection record concerns Rxhomeo Private Limited, with an inspection on May 19, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6009c9a7-c364-46c1-bb05-fe73de6394c6
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1209017
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Rxhomeo Private Limited
1| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2019 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
Other documents for Rxhomeo Private Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.